Annals of Diagnostic Pathology
Volume 12, Issue 4 , Pages 290-292 , August 2008

Splenic micronodular T-cell/histiocyte-rich large B-cell lymphoma

  • Elena Kan, MD

      Affiliations

    • Departments of Pathology and Hematology, Soroka University Medical Center, PO Box 151, Beer-Sheva 84101, Israel
  • ,
  • Itai Levy, MD

      Affiliations

    • Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
  • ,
  • Daniel Benharroch, MD

      Affiliations

    • Departments of Pathology and Hematology, Soroka University Medical Center, PO Box 151, Beer-Sheva 84101, Israel
    • Corresponding Author InformationCorresponding author. Tel.:+972 8 6400920; fax: +972 8 6232770.

References 

  1. Dogan A, Burke JS, Goteri G, et al. Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis. Am J Surg Pathol. 2003;27:903–911
  2. Mollejo M, Algara P, Mateo MS, et al. Large B-cell lymphoma presenting in the spleen: identification of different clinicopathological conditions. Am J Surg Pathol. 2003;27:895–902
  3. Li S, Mann KP, Holden JT. T-cell-rich B-cell lymphoma presenting in the spleen: a clinicopathological analysis of 3 cases. Int J Surg Pathol. 2004;12:31–37
  4. Wang SA, Olson N, Zukerberg L, et al. Splenic marginal zone lymphoma with micronodular T-cell-rich B-cell lymphoma. Am J Surg Pathol. 2006;30:128–132
  5. Fraga M, Sanchez-Verde L, Forteza J, et al. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma. Histopathology. 2002;41:216–229
  6. Bouabdallah R, Mounier N, Guettier C, et al. T-cell/histiocyte-rich large B-cell lymphoma and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. J Clin Oncol. 2003;21:1271–1277

PII: S1092-9134(06)00164-X

doi: 10.1016/j.anndiagpath.2006.12.006

Annals of Diagnostic Pathology
Volume 12, Issue 4 , Pages 290-292 , August 2008